UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
(NYSE:UCB) 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies Data include an open-label extensi...